Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ULTRALIFE CORP Director's Dealing 2023

Dec 11, 2023

34105_dirs_2023-12-11_6287986a-8840-4223-8885-fa60f95db78c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2023-12-07

Reporting Person: FAIN PHILIP A (CFO and Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-12-07 Stock Options for ULBI Common Stock; $.10 par Value $ A 18400 Acquired 2030-12-07 Stock Options for ULBI Common Stock; $.10 par Value (18400) Direct

Footnotes

F1: On December 7, 2023 Ultralife Corporation's Board of Directors awarded 18,400 stock options to Philip A. Fain under Ultralife's 2014 Long-Term Incentive Plan as Amended. These options vest as follows: 6,134 options vest on December 7, 2024; 6,133 options vest on December 7, 2025 and 6,133 options vest on December 7, 2026. The price reported is the volume weighted average price (VWAP) for Ultralife Common Stock on December 7, 2023, the date of award.